Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
1 other identifier
observational
N/A
1 country
1
Brief Summary
Serum Zn status of patients with cystic fibrosis at diagnosis and one year later, compared to a healthy control group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 22, 2005
CompletedJuly 7, 2021
July 1, 2021
September 12, 2005
July 5, 2021
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of cystic fibrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Ghentlead
- Scientific research fund Brugescollaborator
Study Sites (1)
University Hospital Ghent
Ghent, 9000, Belgium
Related Publications (1)
Van Biervliet S, Van Biervliet JP, Robberecht E. Serum zinc in patients with cystic fibrosis at diagnosis and after one year of therapy. Biol Trace Elem Res. 2006 Sep;112(3):205-11. doi: 10.1385/BTER:112:3:205.
PMID: 17057259RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Van Biervliet, MD
University Hospital, Ghent
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 22, 2005
Study Start
September 1, 2004
Last Updated
July 7, 2021
Record last verified: 2021-07